ROC | Logistic Regression 1) | ||
---|---|---|---|
WHO | CDC | ||
AUC | expB (95% CI) | ||
Metabolic syndrome | |||
Total population (n = 246; MS = 61) | 0.680** | 0.703** | CDC 15.66** (5.16-47.59) |
Male Age group 1 (n = 57; MS = 9) | 0.508 | 0.543 | CDC 17.55** (3.90-79.06); Age* 3.65 (1.14-11.70) |
Male Age group 2 (n = 67; MS = 27) | 0.763** | 0.788** | |
Female Age group 1 (n = 39; MS = 12) | 0.642 | 0.636 | WHO 2.76* (1.36-5.60); Age* 0.39 (0.15-0.99) |
Female Age group 2 (n = 83; MS = 13) | 0.693* | 0.664 | |
Insulin resistance | |||
Total population (n = 246; IR = 190) | 0.655** | 0.680** | CDC 10.86** (3.64-32.46) |
Male Age group 1 (n = 57; IR = 39) | 0.551 | 0.582 | CDC 8.18* (1.97-33.96) |
Male Age group 2 (n = 67; IR = 53) | 0.720* | 0.739* | |
Female Age group 1 (n = 39; IR = 32) | 0.777** | 0.777** | CDC 21.77** (3.76-126.02) |
Female Age group 2 (n = 83; IR = 66) | 0.696* | 0.689* |